Clinical Trial Update: A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating Bexmarilimab in combination with standard of care for hematologic malignancies is active but not recruiting. The study aim…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes
• Myelomonocytic Leukemia

Drugs mentioned

• Bexmarilimab (Bexmarilimab)

Snippet

Sponsor: Faron Pharmaceuticals Ltd | Conditions: Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING